HotBalloon球囊消融肺静脉治疗阵发性房颤:日本多中心随机试验
日本前瞻性多中心随机对照研究,将抗心律失常药物难治的症状性阵发性房颤患者按2:1随机分配至HotBalloon消融组或抗心律失常药物治疗组,比较9个月随访期的有效性与安全性。HotBalloon消融组慢性成功率为59.0%,药物治疗组为4.7%(p<0.001),主要并发症发生率为11.2%。
要点
- HotBalloon消融组9个月慢性成功率为59.0%,抗心律失常药物治疗组为4.7%(p<0.001)。
- HotBalloon消融组急性完全肺静脉隔离在98.0%(392/400)的肺静脉和93.0%(93/100)的患者中实现。
- 主要并发症发生率为11.2%(15/134例),肺静脉狭窄(>70%)和短暂性膈神经损伤发生率分别为5.2%和3.7%。
核心结论
- 本研究证明HotBalloon消融在治疗阵发性房颤患者方面优于抗心律失常药物治疗,且安全性良好。
研究设计与样本
- 日本前瞻性多中心随机对照研究,将抗心律失常药物(I至IV类)难治的症状性阵发性房颤患者按2:1比例随机分配至HotBalloon消融组或抗心律失常药物治疗组,在可比的9个月随访期内评估有效性。
主要发现
- HotBalloon消融组100例和抗心律失常药物治疗组43例在17个中心接受治疗。
- HotBalloon消融组急性完全肺静脉隔离在98.0%(392/400)的肺静脉和93.0%(93/100)的患者中实现。
- 9个月有效评估期后慢性成功率HotBalloon消融组为59.0%(n=100),抗心律失常药物治疗组为4.7%(n=43;p<0.001)。
- 主要并发症发生率为11.2%(15/134例),肺静脉狭窄(>70%)和短暂性膈神经损伤发生率分别为5.2%和3.7%。
- 平均透视时间为49.4 ± 26.6分钟(n=134),平均手术时长为113.9 ± 31.9分钟(n=133)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Point-by-point catheter ablation is an established treatment for drug-refractory paroxysmal atrial fibrillation (PAF). However, it is time consuming, requires excellent technique to achieve complete pulmonary vein (PV) isolation, and is associated with severe complications. OBJECTIVES: The purpose of this study was to evaluate the safety and effectiveness of a HotBalloon ablation (HBA) compared with antiarrhythmic drug therapy (ADT) for the treatment of PAF. METHODS: A prospective multicenter randomized controlled study was conducted in Japan. Patients with symptomatic PAF refractory to antiarrhythmic drugs (Class I to IV) were randomized to HBA or ADT at a 2:1 ratio and assessed for effectiveness in a comparable 9-month follow-up period. RESULTS: A total of 100 patients in the HBA group and 43 patients in the ADT group received treatment at 17 sites. HBA procedure produced acute complete PV isolation in 98.0% (392 of 400) of the PVs and in 93.0% (93 of 100) of patients in the HBA group. The chronic success rates after the 9-month effective evaluation period were 59.0% in the HBA group (n = 100) and 4.7% in the ADT group (n = 43; p < 0.001). The incidence of major complications was 11.2% (15 of 134 patients). The incidences of PV stenosis (>70%) and transient phrenic nerve injury were 5.2% and 3.7%, respectively. The mean fluoroscopy time was 49.4 ± 26.6 min (n = 134), and the mean procedure duration was 113.9 ± 31.9 min (n = 133). CONCLUSIONS: This study demonstrates the superiority of HBA compared with ADT for treatment of patients with PAF, and a favorable safety profile.
引用
- Sohara H, Ohe T, Okumura K, et al. HotBalloon Ablation of the Pulmonary Veins for Paroxysmal AF: A Multicenter Randomized Trial in Japan. J Am Coll Cardiol. 2016. PMID: 28007137. doi:10.1016/j.jacc.2016.10.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。